Maxim lowered the firm’s price target on Research Solutions (RSSS) to $5 from $6 and keeps a Buy rating on the shares. The company’s revenue was below estimates and consensus due to churn in B2C and declines in Transactions revenue, while adjusted EBITDA was in line with consensus and beat Maxim estimate due to cost controls and continued margin expansion, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RSSS: